Cao Q, Hajosch A, Kast RE, Loehmann C, et al. Tumor Treating Fields (TTFields) combined with the drug repurposing approach CUSP9v3 induce metabolic reprogramming and synergistic anti-glioblastoma activity in vitro. Br J Cancer 2024 Feb 23. doi: 10.1038/s41416-024-02608.
PMID: 38396172